Opendata, web and dolomites

VEMoS SIGNED

Virtual eye model system for personalised refractive surgery treatment

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 VEMoS project word cloud

Explore the words cloud of the VEMoS project. It provides you a very rough idea of what is the project "VEMoS" about.

eye    drivers    241bn    personalised    action    reported    decision    population    clinics    revenue    life    2010    simulations    measurable    hours    standardise    equal    39    plan    quality    independent    patient    diagnostic    economic    treatments    aberrometer    predicted    28    2m    3m    chuc    create    workers    refractive    death    2026    mature    manufacturing    vulnerable    revolutionise    spent    ec    network    uncorrected    icpermed    cso    global    medicine    customer    clients    employments    2050    clinical    deficits    elderly    groups    145    responsible    health    patented    software    hardware    virtual    neural    productivity    tomographer    commercialisation    post    ophthalmology    children    ophthalmic    driving    risk    progress    innovation    topographer    screens    innovative    combining    front    skills    vision    almost    social    impacts    vissum    58    successful    surgery    myopia    time    vemos    provides    incidence    full    outcomes    accumulated    impairments    worldwide    companies    tech    reduce    quantified    model    2022    educational    50    ms    aging    rates    37m    generating    profit    simulation    revolutionary    auh    satisfaction   

Project "VEMoS" data sheet

The following table provides information about the project.

Coordinator
VALCASADO SA 

Organization address
address: EBANISTAS 4
city: ALCORCON
postcode: 28923
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Spain [ES]
 Total cost 3˙935˙335 €
 EC max contribution 2˙997˙269 € (76%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-EIC-FTI-2018-2020
 Funding Scheme IA
 Starting year 2019
 Duration (year-month-day) from 2019-12-01   to  2022-11-30

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    VALCASADO SA ES (ALCORCON) coordinator 1˙426˙919.00
2    COSTRUZIONI STRUMENTI OFTALMICI C.S.O. SRL IT (BADIA A SETTIMO) participant 761˙902.00
3    AARHUS UNIVERSITETSHOSPITAL DK (AARHUS) participant 406˙371.00
4    CENTRO HOSPITALAR E UNIVERSITARIO DE COIMBRA E.P.E. PT (COIMBRA) participant 402˙076.00

Map

 Project objective

The incidence of myopia is predicted to rise from 28% of the global population in 2010 to almost 50% in 2050. Factors such as population aging and increase of hours spent in front of screens are driving the increase in global eye deficits. Vision impairments reduce the quality of life, affect economic and educational opportunities and increase the risk of death. This is particularly important for vulnerable groups such as elderly, children, workers and drivers. Overall, WHO reported that uncorrected vision was responsible for €241bn of productivity loss per year worldwide. Our innovative Virtual Eye Model System (VEMoS) is based on patented revolutionary ophthalmic diagnostic devices (CSO’s MS-39 tomographer/topographer and the unique open-field aberrometer), as well as on innovative simulation software developed by Vissum. Overall, our innovation provides personalised clinical-decision support based on each patient’s eye measurements and neural network simulations of post-surgery outcomes, improving surgery success and patient satisfaction rates. By combining CSO’s ophthalmic high-tech hardware design, manufacturing and commercialisation skills with Vissum’s refractive surgery and software development and independent clinical testing by CHUC and AUH, this project is expected to bring economic, social and health impacts, including progress towards achieving the EC action plan on personalised medicine “ICPerMed”. Our goal is to mature, scale-up and demonstrate the production of the VEMoS system, targeting ophthalmology clinics as clients, and with the aim to standardise refractive surgery decision making and revolutionise the refractive surgery field with personalised treatments. A successful VEMoS project will allow us to create measurable impacts on our companies, quantified as accumulated revenue of €145.3m in five years (2022-2026), equal to accumulated operating profit of €58.2m, creating 60 full time employments, and generating €37m in reduced customer costs.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "VEMOS" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "VEMOS" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.1.)

Bio-LP-1 (2020)

A novel rapid environmental test for the human pathogen Legionella

Read More  

PATH-TOX (2018)

Artificial Intelligence to transform Drug and Chemical safety testing

Read More  

De-RISC (2019)

De-RISC: Dependable Real-time Infrastructure for Safety-critical Computer

Read More